These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7867083)

  • 1. Multiple CTL specificities against autologous HIV-1-infected BLCLs.
    Ahearne PM; Morgan RA; Sebastian MW; Bolognesi DP; Weinhold KJ
    Cell Immunol; 1995 Mar; 161(1):34-41. PubMed ID: 7867083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equivalent recognition of HIV proteins, Env, Gag and Pol, by CD4+ and CD8+ cytotoxic T-lymphocytes.
    Kundu SK; Merigan TC
    AIDS; 1992 Jul; 6(7):643-9. PubMed ID: 1354446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.
    Ho HN; Hultin LE; Mitsuyasu RT; Matud JL; Hausner MA; Bockstoce D; Chou CC; O'Rourke S; Taylor JM; Giorgi JV
    J Immunol; 1993 Apr; 150(7):3070-9. PubMed ID: 8454874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of retroviral vectors for the analysis of SIV/HIV-specific CD8 T cell responses.
    Negri DR; Buffa V; Leone P; Bona R; Borghi M; Carlini F; De Angelis F; Indraccolo S; Ensoli B; Cara A
    J Immunol Methods; 2004 Aug; 291(1-2):153-63. PubMed ID: 15345313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic T lymphocyte activity in children infected with HIV.
    Froebel KS; Aldhous MC; Mok JY; Hayley J; Arnott M; Peutherer JF
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S83-8. PubMed ID: 7865339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection.
    Wilson SE; Pedersen SL; Kunich JC; Wilkins VL; Mann DL; Mazzara GP; Tartaglia J; Celum CL; Sheppard HW
    AIDS Res Hum Retroviruses; 1998 Jul; 14(11):925-37. PubMed ID: 9686639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rat cytotoxic T lymphocytes against human T-lymphotropic virus type 1-infected cells recognize gag gene and env gene encoded antigens.
    Noguchi Y; Tateno M; Kondo N; Yoshiki T; Shida H; Nakayama E; Shiku H
    J Immunol; 1989 Dec; 143(11):3737-42. PubMed ID: 2479689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular and humoral immune responses to a canarypox vaccine containing human immunodeficiency virus type 1 Env, Gag, and Pro in combination with rgp120.
    AIDS Vaccine Evaluation Group 022 Protocol Team
    J Infect Dis; 2001 Feb; 183(4):563-70. PubMed ID: 11170981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease.
    Carmichael A; Jin X; Sissons P; Borysiewicz L
    J Exp Med; 1993 Feb; 177(2):249-56. PubMed ID: 8093890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of a MHC class I-restricted, CD8 positive cytolytic T-cell response by chimeric HIV-1 virus-like particles in vivo: implications on HIV vaccine development.
    Wagner R; Deml L; Schirmbeck R; Reimann J; Wolf H
    Behring Inst Mitt; 1994 Dec; (95):23-34. PubMed ID: 7755506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cultured blood dendritic cells retain HIV-1 antigen-presenting capacity for memory CTL during progressive HIV-1 infection.
    Fan Z; Huang XL; Zheng L; Wilson C; Borowski L; Liebmann J; Gupta P; Margolick J; Rinaldo C
    J Immunol; 1997 Nov; 159(10):4973-82. PubMed ID: 9366424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell vaccination induces cross-reactive cytotoxic T lymphocytes specific for wild-type and natural variant human immunodeficiency virus type 1 epitopes in HLA-A*0201/Kb transgenic mice.
    Abdel-Motal UM; Friedline R; Poligone B; Pogue-Caley RR; Frelinger JA; Tisch R
    Clin Immunol; 2001 Oct; 101(1):51-8. PubMed ID: 11580226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of primary cytotoxic T lymphocytes specific for the envelope glycoprotein of HIV-1 by deletion of the env amino-terminal signal sequence.
    McChesney M; Tanneau F; Regnault A; Sansonetti P; Montagnier L; Kieny MP; Rivière Y
    Eur J Immunol; 1990 Jan; 20(1):215-20. PubMed ID: 2106442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytolytic T lymphocytes (CTLs) from HIV-1 subtype C-infected Indian patients recognize CTL epitopes from a conserved immunodominant region of HIV-1 Gag and Nef.
    Thakar MR; Bhonge LS; Lakhashe SK; Shankarkumar U; Sane SS; Kulkarni SS; Mahajan BA; Paranjape RS
    J Infect Dis; 2005 Sep; 192(5):749-59. PubMed ID: 16088824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children.
    Buseyne F; Chaix ML; Fleury B; Manigart O; Burgard M; Blanche S; Rouzioux C; Rivière Y
    Virology; 1998 Oct; 250(2):316-24. PubMed ID: 9792842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recognition of two overlapping CTL epitopes in HIV-1 p17 by CTL from a long-term nonprogressing HIV-1-infected individual.
    Harrer T; Harrer E; Barbosa P; Kaufmann F; Wagner R; Brüggemann S; Kalden JR; Feinberg M; Johnson RP; Buchbinder S; Walker BD
    J Immunol; 1998 Nov; 161(9):4875-81. PubMed ID: 9794421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
    Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
    J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies.
    Deml L; Schirmbeck R; Reimann J; Wolf H; Wagner R
    Virology; 1997 Aug; 235(1):26-39. PubMed ID: 9300034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of HTLV-1-specific CTL directed against synthetic and naturally processed peptides in HLA-B*3501 transgenic mice.
    Schönbach C; Nokihara K; Bangham CR; Kariyone A; Karaki S; Shida H; Takatsu K; Egawa K; Wiesmüller KH; Takiguchi M
    Virology; 1996 Dec; 226(1):102-12. PubMed ID: 8941327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
    Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
    J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.